Alliant Health Solutions, Inc.

allianthealth.org

Alliant Health Solutions is a nonprofit organization driven to make health care better in the United States by improving quality of care, increasing the value of health care, and promoting prevention and treatment for chronic illnesses. Our family of companies provide professional services to state, federal and private partners, supporting the effective administration of health care programs and improvement initiatives. Alliant has three primary lines of service offerings that leverage evidenced-based methods, data and technology, and clinical expertise

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

LILLY LAUNCHES DIGITAL HEALTH OPEN INNOVATION CHALLENGE TO HELP TRANSFORM ATOPIC DERMATITIS CARE

Eli Lilly and Company | September 16, 2020

news image

Eli Lilly and Company has launched an open innovation challenge for individuals and teams across the United States to submit inspiring digital health solutions that can help make life better for people living with atopic dermatitis. The challenge, "Transforming Atopic Dermatitis Care: Enhancing Quality of Life and Patient Care for People Living with Inflammatory Skin Diseases," focuses on leveraging digital technologies to enhance care and improve health and well-being for people with ...

Read More

Business Insights

LEXISNEXIS® REED TECH™ AND SCHLAFENDER HASE® ALLIANCE PROVIDES MUTUAL CUSTOMER BENEFITS FOR PHARMACEUTICAL AND MEDICAL DEVICE COMPANIES

LexisNexis Reed Tech | April 27, 2022

news image

Reed Technology and Information Services Inc. a leading provider of data management and analytics solutions for the life sciences industry, announced an alliance with Schlafender Hase®, the market leader for intelligent, automated proofreading software and services for regulated industries. Current and prospective customers of both companies can leverage exclusive benefits as part of this new alliance ecosystem. Pharmaceutical labelers who have regulatory deadlines for US FDA can benefit fro...

Read More

Pharma Tech

SCINEURO PHARMACEUTICALS AND MABYLON AG TO COLLABORATE ON DEVELOPMENT OF NOVEL THERAPEUTICS FOR NEUROLOGICAL DISEASES

SciNeuro Pharmaceuticals | October 26, 2021

news image

SciNeuro Pharmaceuticals a leader in the discovery and development of innovative therapeutics for the treatment of neurological diseases, and Mabylon AG, a leader in the discovery and characterization of human-derived antibodies against therapeutic targets, today announced the establishment of a multi-program collaboration and license agreement. Under the collaboration, MabSciNeuro and Mabylon will collaborate on multiple targets that encompass serious neurological diseases including TAR DNA bin...

Read More

Pharma Tech

NUCLEAI ANNOUNCES A PARTNERSHIP WITH SIRONA DX FOR AI-DRIVEN DISCOVERY OF NOVEL SPATIAL BIOMARKERS IN SOLID TUMORS

Nucleai and Sirona Dx | July 14, 2022

news image

Nucleai, a leader in AI-powered spatial biology transforming precision medicine by unlocking the power of pathology data, and Sirona Dx, a leading provider of multiomic single-cell analytical services, today announced a collaboration to advance the discovery of novel spatial biomarkers in solid tumors. The partnership combines Nucleai’s powerful AI spatial analytics platform with Sirona Dx’s leading multiplex assay development expertise to identify novel spatial signatures in high-pl...

Read More
news image

LILLY LAUNCHES DIGITAL HEALTH OPEN INNOVATION CHALLENGE TO HELP TRANSFORM ATOPIC DERMATITIS CARE

Eli Lilly and Company | September 16, 2020

Eli Lilly and Company has launched an open innovation challenge for individuals and teams across the United States to submit inspiring digital health solutions that can help make life better for people living with atopic dermatitis. The challenge, "Transforming Atopic Dermatitis Care: Enhancing Quality of Life and Patient Care for People Living with Inflammatory Skin Diseases," focuses on leveraging digital technologies to enhance care and improve health and well-being for people with ...

Read More
news image

Business Insights

LEXISNEXIS® REED TECH™ AND SCHLAFENDER HASE® ALLIANCE PROVIDES MUTUAL CUSTOMER BENEFITS FOR PHARMACEUTICAL AND MEDICAL DEVICE COMPANIES

LexisNexis Reed Tech | April 27, 2022

Reed Technology and Information Services Inc. a leading provider of data management and analytics solutions for the life sciences industry, announced an alliance with Schlafender Hase®, the market leader for intelligent, automated proofreading software and services for regulated industries. Current and prospective customers of both companies can leverage exclusive benefits as part of this new alliance ecosystem. Pharmaceutical labelers who have regulatory deadlines for US FDA can benefit fro...

Read More
news image

Pharma Tech

SCINEURO PHARMACEUTICALS AND MABYLON AG TO COLLABORATE ON DEVELOPMENT OF NOVEL THERAPEUTICS FOR NEUROLOGICAL DISEASES

SciNeuro Pharmaceuticals | October 26, 2021

SciNeuro Pharmaceuticals a leader in the discovery and development of innovative therapeutics for the treatment of neurological diseases, and Mabylon AG, a leader in the discovery and characterization of human-derived antibodies against therapeutic targets, today announced the establishment of a multi-program collaboration and license agreement. Under the collaboration, MabSciNeuro and Mabylon will collaborate on multiple targets that encompass serious neurological diseases including TAR DNA bin...

Read More
news image

Pharma Tech

NUCLEAI ANNOUNCES A PARTNERSHIP WITH SIRONA DX FOR AI-DRIVEN DISCOVERY OF NOVEL SPATIAL BIOMARKERS IN SOLID TUMORS

Nucleai and Sirona Dx | July 14, 2022

Nucleai, a leader in AI-powered spatial biology transforming precision medicine by unlocking the power of pathology data, and Sirona Dx, a leading provider of multiomic single-cell analytical services, today announced a collaboration to advance the discovery of novel spatial biomarkers in solid tumors. The partnership combines Nucleai’s powerful AI spatial analytics platform with Sirona Dx’s leading multiplex assay development expertise to identify novel spatial signatures in high-pl...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us